3:09
- news
- February 5, 2021
Johnson & Johnson files for FDA emergency use authorization for COVID-19 vaccine
The single-dose vaccine is 85% effective at preventing severe illness and 100% effective at preventing hospitalization and death, according to the pharmaceutical giant.